Linagliptin/metformin - Boehringer Ingelheim/Eli Lilly and Company
At a glance
- Drug Originator Boehringer Ingelheim
- Drug Licenced by Eli Lilly and Company
- Drug Class Alkynes; Antihyperglycaemics; Biguanides; Insulin sensitisers; Piperidines; Purines; Quinazolines; Small molecules
- Mechanism of Action AMP activated protein kinase stimulants; Dipeptidyl peptidase 4 inhibitors; Gluconeogenesis inhibitors
- USA Patent Applicants BOEHRINGER INGELHEIM
- USA Patents 37
- NDAs 2
- International Patents 390
- Patent Applications 141
Table of Contents

Disclaimer